$28.26
-0.230 (-0.81%)
At Close: Jun 03, 2026
STAAR Surgical supplies implantable lenses for vision correction, serving ophthalmic surgeons and clinics globally with proprietary tech.
Staar Surgical Co (STAA) Stock Down 7.3% -- Now Undervalued? GF Score: 81/100
08:40pm, Thursday, 28'th May 2026
On May 28, 2026, Staar Surgical Co (STAA) shares fell 7.3% to a current price of $29.08. This decline comes amidst a volatile trading period, as the stock has e
STAAR Surgical Company (STAA) Discusses Differentiation of EVO ICL Technology and Market Trends in Refractive Surgery Transcript
01:20am, Thursday, 28'th May 2026
STAAR Surgical Company (STAA) Discusses Differentiation of EVO ICL Technology and Market Trends in Refractive Surgery Transcript
STAAR Surgical Announces Participation in Upcoming Investor Conferences
04:01pm, Thursday, 21'st May 2026
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
STAAR Surgical Q1 2026: Early Signs Of A Durable Turnaround
10:10am, Saturday, 16'th May 2026
STAAR Surgical Company delivered a robust 1Q26 beat, with revenue up 119% YoY to $93.5M and a swing to $5.2M net income. China's market rebound, normalized inventory, and rapid EVO+ ICL adoption drove
Why It's Time To Take Profits In This Top-Rated Medical Stock
12:06pm, Thursday, 14'th May 2026
Staar Surgical shares catapulted Thursday after the eye surgery outlet obliterated first-quarter profit expectations.
STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript
01:20am, Thursday, 14'th May 2026
STAAR Surgical Company (STAA) Q1 2026 Earnings Call Transcript
STAAR Surgical Q1 Earnings Call Highlights
12:14am, Thursday, 14'th May 2026
STAAR Surgical NASDAQ: STAA said its first quarter of 2026 marked a sharp rebound in sales and profitability, driven by strong demand in China, continued growth in the U.S. and tighter cost controls f
Compared to Estimates, Staar Surgical (STAA) Q1 Earnings: A Look at Key Metrics
06:30pm, Wednesday, 13'th May 2026
While the top- and bottom-line numbers for Staar Surgical (STAA) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics co
Staar Surgical (STAA) Tops Q1 Earnings and Revenue Estimates
06:15pm, Wednesday, 13'th May 2026
Staar Surgical (STAA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to a loss of $0.52 per share a year ago.
STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
04:01pm, Monday, 04'th May 2026
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, t
A Look at Staar Surgical Co (STAA) After 3.1% Gain -- GF Value $29.11 vs Price $27.19
06:18pm, Friday, 01'st May 2026
On May 01, 2026, Staar Surgical Co (STAA) shares rose 3.1% today, bringing the current price to $27.19. Over the past 52 weeks, the stock has fluctuated between
McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:06am, Thursday, 30'th Apr 2026
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Staar Surgical (STAA) Earnings Expected to Grow: What to Know Ahead of Q1 Release
11:02am, Wednesday, 29'th Apr 2026
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
STAAR Surgical Shares Jump 25% on Blowout $90M Sales Outlook
12:32pm, Thursday, 09'th Apr 2026
STAAR Surgical (STAA) stock surged more than 25% on Thursday after the ophthalmic implant maker projected first-quarter net sales would top $90 million, more th
Sign In
Buy STAA